Abstract
Systemic sclerosis (SSc) can lead to dyspnea and respiratory failure through multiple mechanisms, making a precise diagnosis particularly challenging, especially amid the current COVID-19 pandemic. In this report, we present a case involving a 26-year-old female who had previously undiagnosed SSc. She experienced acute respiratory failure necessitating orotracheal intubation. Following an extensive evaluation, the patient exhibited skin thickening, kidney failure, thrombocytopenia, microangiopathic anemia, and an antinuclear antibody with a nuclear fine speckled pattern at a titer of 1:320. A diagnosis of SSc complicated by scleroderma renal crisis (SRC) was established. The patient’s condition improved after undergoing hemodialysis, receiving an angiotensin-converting enzyme inhibitor, and undergoing cyclophosphamide treatment. Subsequently, she demonstrated sustained improvement during a follow-up period of 20 months.
Similar content being viewed by others
References
Volkmann ER, Andréasson K, Smith V (2022) Systemic sclerosis. Lancet. https://doi.org/10.1016/S0140-6736(22)01692-0
Perelas A, Silver RM, Arrossi AV, Highland KB (2020) Systemic sclerosis-associated interstitial lung disease. Lancet Respir Med 8:304–320. https://doi.org/10.1016/S2213-2600(19)30480-1
Cole A, Ong VH, Denton CP (2022) Renal disease and systemic sclerosis: an update on scleroderma renal crisis. Clin Rev Allergy Immunol 1:1–14. https://doi.org/10.1007/S12016-022-08945-X/FIGURES/3
Moinzadeh P, Kuhr K, Siegert E, Blank N, Sunderkoetter C, Henes J et al (2020) Scleroderma renal crisis: risk factors for an increasingly rare organ complication. J Rheumatol 47:241–248. https://doi.org/10.3899/JRHEUM.180582
Jaeger VK, Wirz EG, Allanore Y, Rossbach P, Riemekasten G, Hachulla E et al (2016) Incidences and risk factors of organ manifestations in the early course of systemic sclerosis: a longitudinal EUSTAR study. PLoS ONE 11:e0163894. https://doi.org/10.1371/JOURNAL.PONE.0163894
Avouac J, Walker UA, Hachulla E, Riemekasten G, Cuomo G, Carreira PE et al (2016) Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective study. Ann Rheum Dis 75:103–109. https://doi.org/10.1136/ANNRHEUMDIS-2014-205295
Bunn CC, Denton CP, Shi-Wen X, Knight C, Black CM (1998) Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis. Rheumatology 37:15–20. https://doi.org/10.1093/RHEUMATOLOGY/37.1.15
Steen VD, Medsger TA, Steen V (1998) Case–control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis. Arthritis Rheum 41:1613–1619. https://doi.org/10.1002/1529-0131
Hachulla E, Agard C, Allanore Y, Avouac J, Bader-Meunier B, Belot A et al (2021) French recommendations for the management of systemic sclerosis. Orphanet J Rare Dis 16:1–61. https://doi.org/10.1186/S13023-021-01844-Y/FIGURES/5
Hughes M, Kahaleh B, Denton CP, Mason JC, Matucci-Cerinic M (2021) ANCA in systemic sclerosis, when vasculitis overlaps with vasculopathy: a devastating combination of pathologies. Rheumatology 60:5509–5516. https://doi.org/10.1093/RHEUMATOLOGY/KEAB278
Nagaraja V (2019) Management of scleroderma renal crisis. Curr Opin Rheumatol 31:223–230. https://doi.org/10.1097/BOR.0000000000000604
Tyndall AJ, Bannert B, Vonk M, Airò P, Cozzi F, Carreira PE et al (2010) Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 69:1809–1815. https://doi.org/10.1136/ARD.2009.114264
Distler O, Assassi S, Cottin V, Cutolo M, Danoff SK, Denton CP et al (2020) Predictors of progression in systemic sclerosis patients with interstitial lung disease. Eur Respir J. https://doi.org/10.1183/13993003.02026-2019
Juárez M, Misischia R, Alarcón GS (2003) Infections in systemic connective tissue diseases: systemic lupus erythematosus, scleroderma, and polymyositis/dermatomyositis. Rheum Dis Clin N Am 29:163–184. https://doi.org/10.1016/S0889-857X(02)00100-X
Pagkopoulou E, Arvanitaki A, Daoussis D, Garyfallos A, Kitas G, Dimitroulas T (2019) Comorbidity burden in systemic sclerosis: beyond disease-specific complications. Rheumatol Int 39(9):1507–1517. https://doi.org/10.1007/S00296-019-04371-Z
Orlandi M, Landini N, Sambataro G, Nardi C, Tofani L, Bruni C et al (2022) The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19. Rheumatology 61:1600–1609. https://doi.org/10.1093/RHEUMATOLOGY/KEAB615
Haque A, Kiely DG, Condliffe R, Kovacs G, Thompson AAR (2021) Pulmonary hypertension phenotypes in patients with systemic sclerosis. Eur Respir Rev. https://doi.org/10.1183/16000617.0053-2021
Bruni C, Ross L (2021) Cardiac involvement in systemic sclerosis: getting to the heart of the matter. Best Pract Res Clin Rheumatol 35:101668. https://doi.org/10.1016/J.BERH.2021.101668
Hanfi SH, Lalani TK, Saghir A, McIntosh LJ, Lo HS, Kotecha HM (2021) COVID-19 and its mimics: what the radiologist needs to know. J Thorac Imaging 36:W1-10. https://doi.org/10.1097/RTI.0000000000000554
Acknowledgements
JIVDL and ASF collected the data, analyzed the results, and wrote the manuscript; PDSB, RM, ACMR, RMRP, and APLA designed the study, analyzed the results, critically reviewed the manuscript, and contributed to the final version.
Funding
This research did not receive any specific grants from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All the authors declare that they have no conflicts of interest related to this article.
Compliance with ethical standards
All the procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee. The patient signed an informed consent form authorizing the use of the image and access to her electronic medical record.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rosa Maria R. Pereira: In memoriam.
RMRP is deceased.
Special thanks to Dr. Ricardo Manoel de Oliveira and the RDO Diagnósticos Médicos laboratory for conducting the anti-RNA-polymerase III assay.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Landim, J.I.V.D., Franco, A.S., Sampaio-Barros, P.D. et al. Respiratory failure in systemic sclerosis. Rheumatol Int (2023). https://doi.org/10.1007/s00296-023-05482-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00296-023-05482-4